RESEARCH-USE BIOSIMILAR ANTIBODY
Evunzekibart
Monoclonal antibody · IgG4
Evunzekibart (ATOR-1017) is an Fc-γ receptor conditional 4-1BB agonist and IgG4-type antibody. Evunzekibart can be used as monotherapy or in combination with anti-PD1 to exert anticancer activity.
TARGETTNFRSF9
YMonoclonal antibody
CATALOGSC-BS-551
CATALOG NUMBERSC-BS-551
MOLECULAR WEIGHTApprox. 144.42 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Evunzekibart (ATOR-1017) is an Fc-γ receptor conditional 4-1BB agonist and IgG4-type antibody. Evunzekibart can be used as monotherapy or in combination with anti-PD1 to exert anticancer activity.
Evunzekibart is a recombinant research-use antibody directed against TNFRSF9.